Skip to main content

Advancing Autism Clinical Trials Through Research

Is Your Child Struggling with Autism Symptoms?

Discover a New Path to Wellness Through Clinical Trials

Autism Spectrum Disorder (ASD) affects millions of individuals globally, causing difficulties in social communication, behavioral challenges, and restricted interests. If your child has been diagnosed with ASD, participating in autism clinical trials could offer access to innovative treatment options designed to address core and associated symptoms like irritability.

Revive Research Institute is now enrolling participants in autism clinical trials to investigate innovative treatment options for children and adolescents experiencing irritability related to ASD.

Are You Eligible to Participate?

To qualify for the autism clinical trials, participants must:

  • Male or female patients 13 to 17 years of age.
  • CGI-S score >4 with respect to irritability associated with ASD at Screening and Baseline.

*Additional criteria may apply
*Participation in autism spectrum disorder clinical trials in Elgin offers an opportunity to receive expert care, free study-related treatment, and consistent health monitoring by experienced medical professionals.

Please provide YOUR contact information only.
For more info, please visit Privacy Policy.
Autism Spectrum Disorder Clinical Trials Flyer

Understanding Autism Spectrum Disorder

Autism Spectrum Disorder is a neurodevelopmental disorder marked by challenges in verbal and non-verbal communication, social interaction, and repetitive behaviors. According to the Centers for Disease Control and Prevention (CDC), Autism Spectrum Disorder (ASD) affects approximately 1 in 36 children in the United States.

Many individuals with autism also experience additional challenges like aggression, tantrums, or self-injurious behaviors, which significantly impact their quality of life and caregiver burden.

About Our Autism Clinical Trials in Elgin

We are currently enrolling pediatric participants aged 13–17 years in autism spectrum disorder clinical trials in Elgin as part of a Phase 3 study evaluating Lumateperone, an investigational medication. This randomized, double-blind, placebo-controlled study aims to determine the efficacy and safety of Lumateperone in reducing irritability symptoms.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

What to Expect?

If your child is living with Autism Spectrum Disorder and experiencing symptoms like irritability, they may qualify for a paid clinical trial exploring potential treatment options. After completing the interest form above, a research coordinator will reach out to conduct a brief pre-screening to determine initial eligibility.

If your child qualifies, you will be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and risks. Following consent, you and your child will be invited to a screening visit at our clinical research site. During this visit, we’ll review your child’s medical history, conduct physical exams, and perform assessments to confirm eligibility.

Our experienced team is here to guide you every step of the way. We encourage you to ask any questions you may have. Your participation helps shape future treatments for Autism Spectrum Disorder.

Age

13–17 Years

Gender

Male & Female

Location

Elgin, IL

Understanding Autism Spectrum Disorder

Autism Spectrum Disorder Clinical Trials

Autism Spectrum Disorder (ASD) may be influenced by a combination of:

  • Genetic factors
  • Prenatal exposures (e.g., maternal infections or medications during pregnancy)
  • Advanced parental age
  • Low birth weight or complications at birth
  • Environmental factors (currently under investigation)

Common characteristics of ASD include:

  • Difficulties in social interaction and communication
  • Repetitive behaviors or restricted interests
  • Challenges with change in routine
  • Sensory sensitivities (e.g., to sound, light, or textures)
  • Emotional regulation difficulties, including irritability
  • Varying levels of intellectual and language abilities

ASD is a neurodevelopmental disorder, typically appearing by age 2 or 3. While there is no known cure, early diagnosis and intervention; including behavioral therapies, educational support, and certain medications, can significantly improve outcomes. Participation in Autism Spectrum Disorder clinical trials may provide access to potential treatments that aim to support behavioral and emotional well-being. These trials offer a structured and supportive environment monitored by experienced medical professionals.

Frequently Asked Questions (FAQs)

What is Autism Spectrum Disorder (ASD)?

ASD is a developmental condition characterized by difficulties in communication, social interactions, and repetitive behaviors. It can present varying degrees of severity across individuals.

What causes ASD?

The exact cause of ASD is unknown, but research suggests a combination of genetic and environmental factors. There is no single test to diagnose it, and symptoms often appear by age 2 or 3.

What treatments are available for autism?

Currently, there is no cure for autism, but interventions such as behavioral therapy, speech therapy, and certain medications help manage symptoms. Autism clinical trials are helping to identify new treatments for autism that may be more effective and safer.

What are the risks of participating in a clinical trial?

All clinical trials carry some risk, including potential side effects from investigational drugs. However, participants are closely monitored, and safety is a top priority.

Is there any compensation for participating?

Yes, participants may be eligible for compensation for time and travel. All study-related procedures and medications are provided at no cost.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com